{"protocolSection":{"identificationModule":{"nctId":"NCT06470815","orgStudyIdInfo":{"id":"SRM-2024-01"},"organization":{"fullName":"Silk Road Medical","class":"INDUSTRY"},"briefTitle":"ROADSTER 3 Extended Follow-up Sub-Study","officialTitle":"Long-Term Follow-up Study of ROADSTER 3 Patients"},"statusModule":{"statusVerifiedDate":"2024-06","overallStatus":"ENROLLING_BY_INVITATION","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2024-07","type":"ESTIMATED"},"primaryCompletionDateStruct":{"date":"2029-07","type":"ESTIMATED"},"completionDateStruct":{"date":"2029-07","type":"ESTIMATED"},"studyFirstSubmitDate":"2024-06-17","studyFirstSubmitQcDate":"2024-06-17","studyFirstPostDateStruct":{"date":"2024-06-24","type":"ACTUAL"},"lastUpdateSubmitDate":"2024-06-17","lastUpdatePostDateStruct":{"date":"2024-06-24","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Silk Road Medical","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The study objective is to evaluate long-term outcomes for participants enrolled in the ROADSTER 3 study and treated with the ENROUTE Transcarotid Stent System (TSS) and ENROUTE Transcarotid Neuroprotection System (NPS).","detailedDescription":"This is an open label, single arm, multi-center post-market study evaluating long-term outcomes for participants at standard risk for adverse events from carotid endarterectomy who underwent carotid revascularization with the ENROUTE Transcarotid Stent System and the ENROUTE Transcarotid Neuroprotection System in the ROADSTER 3 study."},"conditionsModule":{"conditions":["Carotid Artery Diseases"],"keywords":["Long-term Follow-up","TCAR"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"CASE_ONLY","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":400,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Standard-risk patients who underwent carotid intervention","description":"Symptomatic or asymptomatic patients with a discrete lesion located in the internal carotid artery (ICA) with or without involvement of the contiguous common carotid artery (CCA), who underwent carotid artery revascularization.","interventionNames":["Procedure: Transcarotid Artery Revascularization (TCAR)"]}],"interventions":[{"type":"PROCEDURE","name":"Transcarotid Artery Revascularization (TCAR)","description":"Carotid artery revascularization treated with the FDA-cleared ENROUTE Transcarotid NPS in conjunction with the FDA-approved ENROUTE Transcarotid Stent","armGroupLabels":["Standard-risk patients who underwent carotid intervention"],"otherNames":["Carotid Revascularization","Carotid Artery Stenting"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Ipsilateral Stroke","description":"Ipsilateral stroke at 2-years, 3-years, 4-years, and 5-years following the index procedure","timeFrame":"2-years, 3-years, 4-years, and 5-years following the index procedure"},{"measure":"Ipsilateral Stroke Mortality","description":"Ipsilateral stroke mortality at 2-years, 3-years, 4-years, and 5-years following the index procedure","timeFrame":"2-years, 3-years, 4-years, and 5-years following the index procedure"},{"measure":"In-stent Restenosis","description":"In-stent restenosis â‰¥70% at 2-years and 5-years","timeFrame":"2-years and 5-years following the index procedure"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Participants who were enrolled in the ROADSTER 3 study and treated with the ENROUTE TSS and ENROUTE NPS\n* Able to provide informed consent\n\nExclusion Criteria:\n\n* Participants who have exited the ROADSTER 3 study early (i.e., prior to completion of protocol required follow-up) will not participate in the sub-study","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"79 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Participants who were enrolled in the ROADSTER 3 study","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"locations":[{"facility":"Beth Israel Deaconess Medical Center","city":"Boston","state":"Massachusetts","zip":"02215","country":"United States","geoPoint":{"lat":42.35843,"lon":-71.05977}},{"facility":"Abbott Northwestern","city":"Minneapolis","state":"Minnesota","zip":"55407","country":"United States","geoPoint":{"lat":44.97997,"lon":-93.26384}},{"facility":"Lancaster General Hospital","city":"Lancaster","state":"Pennsylvania","zip":"17602","country":"United States","geoPoint":{"lat":40.03788,"lon":-76.30551}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-07-01"},"conditionBrowseModule":{"meshes":[{"id":"D000002340","term":"Carotid Artery Diseases"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M5594","name":"Carotid Artery Diseases","asFound":"Carotid Artery Diseases","relevance":"HIGH"},{"id":"M5810","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M5204","name":"Brain Diseases","relevance":"LOW"},{"id":"M5742","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17400","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"}]}},"hasResults":false}